Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China
Qifan Zhan(Ministry of Public Health), Xiao Xu(National Institute of Quality), Qiaonan Shan(Ministry of Public Health), Jian Wu(Sun Yat-sen University), Shengjun Xu(Zhejiang University), Beini Cen, Sunbin Ling(Zhejiang Provincial People's Hospital), Xuyong Wei(Ministry of Public Health), Guangjiang Jiang(Ministry of Public Health), Li Zhuang(Broad Institute), Yang Yang(Sun Yat-sen University), Haiyang Xie(Sun Yat-sen University), Shusen Zheng(Wenzhou University), Tian Shen(Columbia University Irving Medical Center), Di Lu(Fudan University), Qianwei Ye(Ministry of Public Health), Wu Zhang, Jimin Liu(McMaster University)
Cited by 26
Related Papers
Targeting tumor-associated macrophages to synergize tumor immunotherapy
|Signal Transduction and Targeted Therapy|2021|913
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
The Mechanisms of PML-Nuclear Body Formation
|Molecular Cell|2006|517